目的：观察低分子肝素钙治疗脑梗死的有效性和安全性。
Objective: To explore the safety and efficiency of low molecular heparin calcium treating cerebral infarction.
目的：观察低分子肝素钙对2型糖尿病肾病的疗效和安全性。
Objective: To observe the safety and efficacy of low molecular weight heparin calcic in treatment of type2 diabetic nephropathy.
目的观察低分子肝素钙在预防小儿过敏性紫癜肾损害中的作用。
Objective To evaluate the therapeutical effect of low molecular heparin calcium in the prevention of Henoch-Schonlein purpura nephritis (HSPN).
目的观察低分子肝素钙联合东菱克栓酶治疗进展性脑梗死的疗效。
Objective To observe the therapeutic efficacy of combination of low-molecular weight heparin and Batroxobin(DF-521)on progressive stroke.
目的观察低分子肝素钙联合冠心宁治疗不稳定型心绞痛的临床疗效。
Objective To observe the curative effect on treatment of unstable angina with low molecular heparin calcium (LMHC) combined with Guanxinnin injection.
目的观察低分子肝素钠股动脉注射治疗糖尿病下肢血管病变的疗效。
Objective To observe the effect of low molecular weight heparin in treating peripheral diabetic vasculopathy.
目的观察低分子肝素治疗肺原性心脏病肺心病心力衰竭的临床疗效。
Objective To discuss the curative effect on heart failure treated with low molecular heparin (LMH) in pneumocardiac disease.
本研究旨在观察低分子肝素钠防治过敏性紫癜肾损害的临床有效性。
This study is to observe the clinical validity of the LMWH Sodium preventing and controlling the Henoch-Schoenlein Purpura Nephritis.
目的观察低分子肝素联合血管转换酶抑制剂对糖尿病肾病显性蛋白尿的治疗效果。
Objective To investigate the effects of the combination of low molecular weight heparin and ACEI on albuminuria in diabetic nephropathy.
目的观察低分子肝素钙、阿司匹林及其联合应用治疗急性脑梗死的疗效及其安全性。
OBJECTIVE To study the efficacy and safety of low-molecular-weight heparin calcium and aspirin on treating acute cerebral infarction.
目的观察低分子肝素（LMWH）治疗川崎病（KD）急性期血液高凝状态的临床疗效。
Objective To observe the curative effect of low molecular weight heparin(LMWH) on the hypercoagulability in acute Kawasaki disease(KD).
目的：观察低分子肝素(LMWH)治疗慢性肺源性心脏病合并高凝状态的疗效和安全性。
AIM: To investigate the effects and safe of low molecular weight heparins (LMWH) in the treatment of patients with chronic pulmonary heart diseases (CPHD) at hypercoagulability state.
目的观察低分子肝素联合缬沙坦对2型早期糖尿病肾病（DN）患者尿白蛋白排泄率（UAER）的影响。
Objective To investigate the impact of low molecular heparin(LMH)and valsartan on urine albumin excretion rate(UAER)in patients with early type-2 diabetic nephropathy(DN).
目的观察低分子肝素钠对原发性肾病综合征(PNS)患者血浆白介素- 8 (IL - 8)的影响。
Objective To evaluate the effects of low molecular weight heparin (LMWH) on serum interleukin-8 (IL-8) in patients with primary nephrotic syndrome (PNS).
目的观察丹奥和低分子肝素联合治疗进展性脑梗死的疗效及安全性。
ObjectiveTo observe the combined effect and safety of Sodium Ozagrel and Low Molecular Heparin in the treatment of progressive cerebral infraction.
目的：观察奥扎格雷钠、低分子肝素钠联合应用治疗进展性脑梗死的临床疗效。
AIM: To observe the clinical effect of combination therapy with ozagrel and low molecular weight heparin on progressive cerebral infarction.
目的观察在常规治疗肾病综合征的基础上加用低分子右旋糖酐、肝素钠、速尿后患者水肿变化情况。
Objective To observe edema variation in patients with nephrotic syndrome treated with low molecule dextran, nephritic sodium, and furosemide on the basis of general therapy.
目的：观察小剂量低分子肝素钙治疗糖尿病肾病的疗效。
Objective: To observe the curative effect of small dose low molecular heparin calcic in the treatment of diabetic nephropathy.
目的观察舒血宁注射液联合低分子肝素治疗不稳定型心绞痛(uap)的临床疗效。
Objective to investigate the therapeutic effect of Shuxuening injection combined with low molecular heparin in treating of unstable angina pectoris (UAP).
观察低分子量肝素在血液透析中的抗凝效果，比较与普通肝素在护理方面的不同处理。
To observe the anticoagulation effect of low molecular weight heparin on hemodialysis and to study its related nursing aspect.
目的观察低分子量肝素对原发性肾病综合征的治疗作用。
Objective To observe the therapeutic effectiveness of low molecular weight heparin (LMWH) in the treatment of primary nephrotic syndrome.
目的观察地尔硫联合低分子肝素治疗慢性肺源性心脏病的疗效。
Objective To observe the curative effect of diltiazem combined with low molecular weight heparins on chronic pulmonary heart disease (CPHD).
目的观察不同剂量低分子肝素(LMWH)对急性脑梗死(aci)患者的疗效。
Objective To observe the curative effect of different dosages of low molecular weight heparin (LMWH) in patients with acute cerebral infarction (ACI).
目的观察血栓通注射液联合低分子肝素钙治疗不稳定型心绞痛的临床疗效。
Objective To study the clinical effects of Xueshuantong with low molecular weight heparin for unstable angina(UA).
方法：采用MTT比色法，观察缬沙坦和低分子量肝素不同作用时间和不同作用浓度以及二者合用时对高糖刺激系膜细胞增殖的影响。
Methods:The mesangial cell line was treated by valsartan and low molecular weight heparin under different concentrations and times, and the proliferation activity was measured by MTT.
方法：采用MTT比色法，观察缬沙坦和低分子量肝素不同作用时间和不同作用浓度以及二者合用时对高糖刺激系膜细胞增殖的影响。
Methods:The mesangial cell line was treated by valsartan and low molecular weight heparin under different concentrations and times, and the proliferation activity was measured by MTT.
应用推荐